Prosecution Insights
Prosecution Insights
8 pending office actions • 6 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (62%) |
| No statute on record | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SANGHERA, STEVEN G.S. | 1 | 30.4% | +29.4% |
| DAUNER, JOSEPH G | 1 | 56.8% | +34.8% |
| NGUYEN, QUANG | 1 | 38.2% | +52.8% |
| SHUPE, ELIZABETH A | 1 | 63.3% | +49.1% |
| FRITCHMAN, REBECCA M | 1 | 45.7% | +36.1% |
| WU, JULIE ZHEN QIN | 1 | 61.8% | +52.2% |
| NATARAJAN, MEERA | 1 | 62.2% | +16.8% |
| WANG, RUIXUE | 1 | 57.6% | +23.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17751586 | CHIMERIC RECEPTORS TO FLT3 AND METHODS OF USE THEREOF | NATARAJAN, MEERA | 84d overdue |
| 17679521 | METHODS AND SYSTEMS FOR PERFORMING A PATIENT-SPECIFIC IMMUNOTHERAPY PROCEDURE WITH CHAIN-OF-CUSTODY AND CHAIN-OF-IDENTITY BIOLOGICAL SAMPLE TRACKING | WANG, RUIXUE | 31d overdue |
| 19044010 | METHODS AND SYSTEMS FOR SCHEDULING A PATIENT-SPECIFIC IMMUNOTHERAPY PROCEDURE | SANGHERA, STEVEN G.S. | 25d overdue |
| 17814811 | SPLIT CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE | WU, JULIE ZHEN QIN | 23d overdue |
| 18327651 | CHIMERIC TRANSMEMBRANE PROTEINS AND USES THEREOF | NGUYEN, QUANG | 18d overdue |
| 17816076 | MONITORING AND MANAGEMENT OF CELL THERAPY-INDUCED TOXICITIES | FRITCHMAN, REBECCA M | 8d overdue |
| 18175049 | ALLOGENEIC THERAPEUTIC CELLS | SHUPE, ELIZABETH A | 4d overdue |
| 18496588 | FACTORS FOR OPTIMIZING IMMUNOTHERAPY | DAUNER, JOSEPH G | 13d |
| Art Unit | Apps |
|---|---|
| 1643 | 3 |
| 3684 | 1 |
| 1682 | 1 |
| 1631 | 1 |
| 1758 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19044010 | METHODS AND SYSTEMS FOR SCHEDULING A PATIENT-SPECIFIC IMMUNOTHERAPY PROCEDURE | SANGHERA, STEVEN G.S. | 3684 | §103 | Non-Final OA | 25d overdue | Pending | Feb 03, 2025 |
| 18496588 | FACTORS FOR OPTIMIZING IMMUNOTHERAPY | DAUNER, JOSEPH G | 1682 | §103 | Non-Final OA | 13d | Pending | Oct 27, 2023 |
| 18327651 | CHIMERIC TRANSMEMBRANE PROTEINS AND USES THEREOF | NGUYEN, QUANG | 1631 | §103 | Non-Final OA | 18d overdue | Pending | Jun 01, 2023 |
| 18175049 | ALLOGENEIC THERAPEUTIC CELLS | SHUPE, ELIZABETH A | 1643 | Other | Non-Final OA | 4d overdue | Pending | Feb 27, 2023 |
| 17816076 | MONITORING AND MANAGEMENT OF CELL THERAPY-INDUCED TOXICITIES | FRITCHMAN, REBECCA M | 1758 | §103 | Non-Final OA | 8d overdue | Pending | Jul 29, 2022 |
| 17814811 | SPLIT CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE | WU, JULIE ZHEN QIN | 1643 | Other | Final Rejection | 23d overdue | Pending | Jul 25, 2022 |
| 17751586 | CHIMERIC RECEPTORS TO FLT3 AND METHODS OF USE THEREOF | NATARAJAN, MEERA | 1643 | Other | Final Rejection | 84d overdue | Pending | May 23, 2022 |
| 17679521 | METHODS AND SYSTEMS FOR PERFORMING A PATIENT-SPECIFIC IMMUNOTHERAPY PROCEDURE WITH CHAIN-OF-CUSTODY AND CHAIN-OF-IDENTITY BIOLOGICAL SAMPLE TRACKING | WANG, RUIXUE | 1672 | §103 | Final Rejection | 31d overdue | Pending | Feb 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial